These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 983)

  • 21. The effect of ethanol intake on propoxyphene absorption and biotransformation in dogs.
    Olsen H; Aune H; Lilleaasen P; Gulliksen M; Bodd E; Mørland J
    Alcohol Clin Exp Res; 1986 Aug; 10(4):393-6. PubMed ID: 3530016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propoxyphene form maintenance treatment of narcotic addiction.
    Woody GE; Mintz J; Tennant F; O'Brien CP; McLellan AT; Marcovici M
    Arch Gen Psychiatry; 1981 Aug; 38(8):898-900. PubMed ID: 6114721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of evidence of increased lethality due to propoxyphene overdose in the presence of ethanol in male Wistar rats.
    Bodd E; Olsen H; Gulliksen M; Mørland J
    Arch Toxicol; 1985 Jan; 56(3):170-4. PubMed ID: 3977596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propoxyphene napsylate maintenance treatment of narcotic dependence: use of a non-methadone model.
    Tennant FS; Rawson RA
    NIDA Res Monogr; 1982 Apr; 41():246-52. PubMed ID: 6126813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of propoxyphene and norpropoxyphene by chemical ionization mass fragmentography.
    Wolen RL; Ziege EA; Gruber CM
    Clin Pharmacol Ther; 1975 Jan; 17(1):15-20. PubMed ID: 1122667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propoxyphene napsylate maintenance treatment for narcotic dependence: a non-methadone model.
    Tennant FS; Rawson RA
    Drug Alcohol Depend; 1981 Aug; 8(1):79-83. PubMed ID: 6117456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic interaction of propoxyphene with ethanol.
    Sellers EM; Hamilton CA; Kaplan HL; Degani NC; Foltz RL
    Br J Clin Pharmacol; 1985 Mar; 19(3):398-401. PubMed ID: 3986091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro metabolism of propoxyphene in rat liver: reaction of a carbinol metabolite with acetaldehyde.
    Hermansson I; Hermansson J; Stjernström NE
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):257-64. PubMed ID: 6650176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propoxyphene napsylate.
    Lasagna L
    Ann Intern Med; 1976 Nov; 85(5):619-21. PubMed ID: 10824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propoxyphene napsylate detoxification.
    Schmalstieg WJ; Hayden JW; Comstock EG
    Tex Med; 1975 Apr; 71(4):70-6. PubMed ID: 1135758
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical comparison of propoxyphene napsylate and methadone in the treatment of opiate dependence.
    Wang RI; Kochar C; Hasegawa AT; Roh BL
    NIDA Res Monogr; 1982 Apr; 41():253-60. PubMed ID: 6126814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal and fetal blood/brain distribution of d-propoxyphene and norpropoxyphene in rat and dog.
    Due SL; Sullivan HR; Cochrane RL; Page JG; McMahon RE
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):194-202. PubMed ID: 7245195
    [No Abstract]   [Full Text] [Related]  

  • 33. Propoxyphene and norpropoxyphene: influence of diet and fluid on plasma levels.
    Welling PG; Lyons LL; Tse FL; Craig WA
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):559-65. PubMed ID: 1277712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-poisoning with dextropropoxyphene and dextropropoxyphene compounds: the USA experience.
    Finkle BS
    Hum Toxicol; 1984 Aug; 3 Suppl():115S-134S. PubMed ID: 6480011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propoxyphene and norpropoxyphene: influence of type of controlled-release formulation on intra- and intersubject variations.
    Bechgaard H; Baggesen S
    J Pharm Sci; 1980 Nov; 69(11):1327-30. PubMed ID: 7452465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene.
    Inturrisi CE; Colburn WA; Verebey K; Dayton HE; Woody GE; O'Brien CP
    Clin Pharmacol Ther; 1982 Feb; 31(2):157-67. PubMed ID: 7056023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Entrance into brain of dextropropoxyphene and the toxic metabolite norpropoxyphene.
    Way WL; Schou J
    Arch Toxicol Suppl; 1979; (2):367-70. PubMed ID: 288347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propoxyphene and norpropoxyphene: pharmacologic and toxic effects in animals.
    Nickander R; Smits SE; Steinberg MI
    J Pharmacol Exp Ther; 1977 Jan; 200(1):245-53. PubMed ID: 13200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heroin detoxification. A comparison of propoxyphene and methadone.
    Tennant FS; Russell BA; Casas SK; Bleich RN
    JAMA; 1975 Jun; 232(10):1019-22. PubMed ID: 805264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propoxyphene in postmortem toxicology 1976-1978.
    Finkle BS; Caplan YH; Garriott JC; Monforte JR; Shaw RF; Sonsalla PK
    J Forensic Sci; 1981 Oct; 26(4):739-57. PubMed ID: 7299359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.